CD59

gene product
16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20
This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
617 antibodies from 22 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
186 antibodies
Proteintech Group
1 antibody
GeneTex
20 antibodies
Thermo Fisher Scientific Pierce
14 antibodies
Abnova Corporation
18 antibodies
R&D Systems
2 antibodies
LifeSpan BioSciences, Inc.
97 antibodies
Novus Biologicals
72 antibodies
Aviva Systems Biology
19 antibodies
Acris Antibodies GmbH
29 antibodies
Atlas Antibodies
1 antibody
Creative Biomart
74 antibodies
Biorbyt
27 antibodies
RabMAbs
3 antibodies
GenWay
21 antibodies
BioLegend
5 antibodies
RayBiotech, Inc.
6 antibodies
United States Biological
3 antibodies
Abgent
1 antibody
EMD Millipore
2 antibodies
Sigma-Aldrich
3 antibodies
eBioscience, An Affymetrix Company
13 antibodies